Gamma Camera Clinical Trial Analysis

Summary

Global Markets Direct's "Gamma Camera Clinical Trials Analysis" is an essential source of data and information pertaining to product clinical trials being carried out by Gamma Camera manufacturers, globally. The report provides exhaustive information on each clinical investigation study with coverage detailed coverage on the pipeline products these trials are being carried out for.

Scope

• The report provides analysis and review of the key clinical trials being carried out globally and across key Gamma Camera market categories - Gamma Camera
• The report covers information on each product being clinically tested with detailed coverage on the pipeline product profile, the indication it's being investigated for etc.
• The report provides an in-depth analysis of the clinical trials with information on trial phase, trial 0status, trial acronym, purpose, inclusion and exclusion criteria, description, design, intervention, investigator information, primary and secondary end-points and trial results
• The report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by Global Markets Direct's team of industry experts.

Reasons to Buy

• Effectively plan your Mergers and Acquisitions and partnership strategies by identifying companies with the most promising pipeline.
• Stay ahead of the information curve in the fast changing Gamma Camera market.
• Plan in-licensing and out-licensing opportunities through review of pipeline products and technologies.
• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
• Proactively plan and execute your competitive strategies by identifying clinical trials status of the leading competitive products in pipeline.
• Stay ahead of competition by understanding the changing competitive landscape in specific geographies.

Contents

• 1 List of Tables
• 1.2 List of Figures
• 2 Gamma Camera Clinical Trials
  • 2.1 Gamma Camera Clinical Trial By Equipment Type
  • 2.2 Gamma Camera Clinical Trials By Trial Phase and Trial Status
  • 2.3 Gamma Camera Pipeline Products By Development Stage
  • 2.4 Gamma Camera Pipeline Products By Therapy Area
  • 2.5 Gamma Camera RIGS system
    • 2.5.1 A study on RIGS system for colorectal cancer
    • 2.5.2 Pilot Study Using A Humanized CC49 Monoclonal Antibody (HuCC49?CH2) To Localize Recurrent Colorectal Carcinoma
    • 2.5.3 Staging Of Colorectal Cancer: Biology Vs Morphology
• 3 Recent Developments
  • 3.1 Product News
    • 3.1.1 Jun 17, 2009: Dilon Introduces New Software Upgrades For Dilon 6800 Gamma Camera
    • 3.1.2 Feb 03, 2009: Dilon Technologies Announces Release Of Two Collimator For Dilon 6800 Gamma Camera
    • 3.1.3 Dec 03, 2008: Molecular Breast Imaging Identifies Occult Cancer
    • 3.1.4 Dec 02, 2008: Molecular Breast Imaging Has Greater Sensitivity Over Mammography, Ultrasound And MRI For Invasive Lobular Carcinoma
    • 3.1.5 Dec 01, 2008: Molecular Breast Imaging Performs Better Than Ultrasound In Patients With Mammographic Abnormalities
    • 3.1.6 Aug 12, 2008: Dilon Technologies Announces A Transportable Version Of The Dilon 6800 Gamma Camera
    • 3.1.7 Jul 16, 2008: Dilon Technologies Signs Amerinet For Breast-Specific Gamma Imaging
    • 3.1.8 Jun 09, 2008: Legacy Good Samaritan Hospital Surgeons Find BSGI Effective In Determining Extent Of Breast Cancer In Patients With Known Diagnosis
    • 3.1.9 Mar 05, 2008: Bertrand Study Finds Significant Value In Breast-Specific Gamma Imaging (BSGI) As An Adjunctive Procedure In Breast Diagnostics
    • 3.1.10 Nov 07, 2007: Dilon Technologies Explores Improvements In Molecular Breast Imaging
    • 3.1.11 Aug 10, 2007: BSGI Posts Higher Sensitivity Than Mammography Or MRI For The Detection Of Ductal Carcinoma In Situ
  • 3.2 Clinical Trials
    • 3.2.1 Dec 03, 2008: Molecular Breast Imaging Identifies Occult Cancer
    • 3.2.2 Dec 02, 2008: Molecular Breast Imaging Has Greater Sensitivity Over Mammography, Ultrasound And MRI For Invasive Lobular Carcinoma
    • 3.2.3 Dec 01, 2008: Molecular Breast Imaging Performs Better Than Ultrasound In Patients With Mammographic Abnormalities
• 4 Appendix
  • 4.1 Methodology
    • 4.1.1 Coverage
    • 4.1.2 Secondary Research
    • 4.1.3 Primary Research
    • 4.1.4 Expert Panel Validation
  • 4.2 Contact Us
  • 4.3 About Global Markets Direct
  • 4.4 Disclaimer
• 1 List of Tables
  • Table 1: Gamma Camera Clinical Trial By Equipment Type
  • Table 2: Gamma Camera Clinical Trials By Trial Phase and Trial Status
  • Table 3: Gamma Camera Pipeline Products By Development Stage
  • Table 4: Gamma Camera Pipeline Products By Therapy Area
  • Table 5: RIGS system - A study on RIGS system for colorectal cancer
  • Table 6: RIGS system - Pilot Study Using A Humanized CC49 Monoclonal Antibody (HuCC49?CH2) To Localize Recurrent Colorectal Carcinoma
  • Table 7: RIGS system - Staging Of Colorectal Cancer: Biology Vs Morphology
• 1.2 List of Figures
  • Figure 1: Global Markets Direct Methodology